$MDWD

Fox David Morton purchased $25K of MDWD

Fox David Morton purchased 1,730 shares of MediWound Ltd. (MDWD) at $14.22 on 2026-06-01.

Original reporting
SEC EDGAR · Fox David Morton
Published Jun 2, 2026, 11:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 11:33 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$MDWD
Bullish
medium confidence
Mentioned
$MDWD
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MDWDBullishLow
01

Why it matters

The new information is the specific buy (shares, price, and post-transaction holdings). It may modestly improve sentiment but does not introduce new business fundamentals.

02

Market read

Traders may note insider accumulation, but without accompanying fundamental news the effect is likely limited.

03

What to watch

The filing does not include a 10b5-1 plan and provides no rationale; the purchase size is relatively small versus typical institutional flows.

Relevance 6/10Novelty 5/10Timing: Filed 2026-06-02; reflects purchase executed 2026-06-01

Background

The article is an SEC Form 4 disclosure of an insider open-market purchase by a MediWound director.

Company-level read

Ticker impact

$MDWDBullishMedium confidence
Context

MediWound director Fox David Morton bought 1,730 shares in an open-market transaction on 2026-06-01, signaling insider accumulation.

Expected impact

Low probability of a sustained move; any reaction is likely limited and short-lived.

Evidence & confidence

This is a Form 4 insider purchase with a small dollar value (~$24.6k) and no new operational/financial catalyst disclosed.

Market effects

Minimal; this is company-specific insider activity with no stated sector-wide change.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine liquidity/portfolio actions and do not necessarily imply near-term fundamental upside.

Key entities

  • MediWound Ltd.

    Subject of the Form 4 insider transaction; director Fox David Morton purchased shares on 2026-06-01.

Related articles